Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Karen Vervisch

Add to list
- Conference Paper
- C3
Decreased NEAT1 and MALAT1 levels in HIV-1 positive individuals with high viral load

Clarissa Van Hecke, Sabine Kinloch-de Loes, Tinus Schynkel (UGent) , Eva Malatinková (UGent) , Karen Vervisch (UGent) , Sofie Rutsaert (UGent) and Wim Trypsteen (UGent)

(2019) Research Day & Student Research Symposium.
Add to list
- Conference Paper
- C3
Decreased NEAT1 and MALAT1 levels in HIV-1 positive individuals with high viral load

Clarissa Van Hecke, Sabine Kinloch-de Loes, Tinus Schynkel (UGent) , Eva Malatinková (UGent) , Karen Vervisch (UGent) , Sofie Rutsaert (UGent) , Wim Trypsteen (UGent) and Linos Vandekerckhove (UGent)

(2019) Long noncoding RNAs : from molecular mechanism to functional genetics, Keystone symposium, Abstracts.
Add to list
- Journal Article
- A1
- open access
Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors

Clarissa Van Hecke, Wim Trypsteen (UGent) , Eva Malatinková (UGent) , Ward De Spiegelaere (UGent) , Karen Vervisch (UGent) , Sofie Rutsaert (UGent) , Sabine Kinloch-de Loes, Magdalena Sips (UGent) and Linos Vandekerckhove (UGent)

(2019) EBIOMEDICINE. 41. p.443-454
Add to list
- Conference Paper
- C3
Beneficial impact of early treatment on restriction factor expression profile

Clarissa Van Hecke, Wim Trypsteen (UGent) , Eva Malatinková (UGent) , Ward De Spiegelaere (UGent) , Karen Vervisch (UGent) , Margaret Johnson, Sabine Kinloch-de Loes, Magdalena Sips (UGent) and Linos Vandekerckhove (UGent)

(2018) RETROVIROLOGY. 15(suppl. 1). p.33-33
Add to list
- Conference Paper
- C3
Beneficial impact of early treatment on restriction factor expression profile

Clarissa Van Hecke, Magdalena Sips (UGent) , Eva Malatinková (UGent) , Ward De Spiegelaere (UGent) , Karen Vervisch (UGent) , Margaret Johnson, Sabine Kinloch-de Loes, Wim Trypsteen (UGent) and Linos Vandekerckhove (UGent)

(2018) Retroviruses and Opportunistic infections, 25th Conference, Abstracts.
Add to list
- Journal Article
- A1
- open access
In-depth validation of total HIV-1 DNA assays for quantification of various HIV-1 subtypes

Sofie Rutsaert (UGent) , Ward De Spiegelaere (UGent) , Clarissa Van Hecke, Marie-Angélique De Scheerder (UGent) , Maja Kiselinova (UGent) , Karen Vervisch (UGent) , Wim Trypsteen (UGent) and Linos Vandekerckhove (UGent)

(2018) SCIENTIFIC REPORTS. 8.
Add to list
- Conference Paper
- C3
Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes

Sofie Rutsaert (UGent) , Ward De Spiegelaere (UGent) , Clarissa Van Hecke, Marie-Angélique De Scheerder (UGent) , Maja Kiselinova (UGent) , Karen Vervisch (UGent) , Wim Trypsteen (UGent) and Linos Vandekerckhove (UGent)

(2017) HIV & Hepatitis, 15th European meeting, Abstracts.
Add to list
- Conference Paper
- C3
Beneficial impact of early treatment on restriction factor expression profile

Clarissa Van Hecke, Magdalena Sips (UGent) , Eva Malatinková (UGent) , Ward De Spiegelaere (UGent) , Karen Vervisch (UGent) , Margaret Johnson, Sabine Kinloch-de Loes, Wim Trypsteen (UGent) and Linos Vandekerckhove (UGent)

(2017) Fifth annual meeting Belgian Society for Virology.
Add to list
- Journal Article
- A1
- open access
Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression

Peter Messiaen (UGent) , Ward De Spiegelaere (UGent) , Jose Alcami, Karen Vervisch (UGent) , Petra Van Acker (UGent) , Bruno Verhasselt (UGent) , Pieter Meuwissen (UGent) , Esther Calonge, Nuria Gonzalez, Felix Gutierrez-Rodero, et al.

(2012) PLOS ONE. 7(11).